Skip to main content
. 2015 Dec 15;17:362. doi: 10.1186/s13075-015-0880-2

Fig. 1.

Fig. 1

Flow diagram of the literature selection process. DMARD(−IR) disease-modifying antirheumatic drug(inadequate responder), LTE long-term extension